FDA Approves Novo Nordisk Semaglutide Pill for Weight Loss
π Key Facts β The FDA has approved a pill version of Wegovy. β Novo Nordisk's semaglutide is the active ingredient in the pill. ...
4dWiredHealth
π Key Facts β The FDA has approved a pill version of Wegovy. β Novo Nordisk's semaglutide is the active ingredient in the pill. ...
π Key Facts β FDA approved once-daily oral Wegovy containing semaglutide for weight management. β Starting dose of 1.5 mg costs $149 pe...
π Key Facts β The FDA approved the first-ever GLP-1 pill on Monday. β The pill was developed by Novo Nordisk, a Danish pharmaceutical g...